The Catalist-listed firm says the provisional authorisation from the Health Sciences Authority will allow the firm to export the product and market it in Singapore.
BIOLIDICS Ltd believes that it only became material to disclose that the firm had received approval for its virus test kits from Singapore's Health Sciences Authority after it was certain that the kits could be commercialised.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: